Goldman Sachs
IDXX icon

Goldman Sachs’s Idexx Laboratories IDXX Stock Holding History

Goldman Sachs’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-32,000
Closed -$2.05M – 7385
2015
Q2 		$2.05M Buy
+32,000
New +$2.22M ﹤0.01% 3805
2013
Q4 		– Sell
-4,600
Closed -$229K – 6715
2013
Q3 		$229K Buy
+4,600
New +$221K ﹤0.01% 5759

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Goldman Sachs's IDXX Position: Q2 2026 in Review

Goldman Sachs increased its Idexx Laboratories (IDXX) stake by 3% in Q2 2026, buying an estimated $12.2M and bringing the position to 738,708 shares worth $389M. The position accounts for 0.03% of the portfolio, ranked #483.

Goldman Sachs first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $563M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Goldman Sachs held 738,708 shares of Idexx Laboratories worth $389M as of Q2 2026.
  • Goldman Sachs bought 21,787 Idexx Laboratories shares in Q2 2026, an estimated $12.2M.
  • Idexx Laboratories made up 0.03% of Goldman Sachs's portfolio in Q2 2026, its #483 holding.
  • Goldman Sachs first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's Idexx Laboratories position peaked at $563M in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.